J. Benjamin Guise
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
J. Benjamin Guise's research program focuses on the pharmacological treatment of substance use disorders and related behavioral health interventions. His recent publications investigate the efficacy of gabapentin, particularly in conjunction with buprenorphine-assisted tapers and transition to injectable naltrexone for opioid use disorder. He has also examined the impact of fentanyl on treatment outcomes within outpatient buprenorphine tapers when gabapentin is used as an adjunct therapy. Further studies explore the effects of gabapentin and d-cycloserine, alone and in combination with naloxone, on methadone-maintained individuals within controlled behavioral discrimination procedures.
Guise's work involves collaborations with researchers at the University of Arkansas for Medical Sciences, including Michael Mancino and Alison Oliveto, with whom he has co-authored multiple publications. His scholarship metrics include an h-index of 7, with a total of 14 publications and 200 citations.
Metrics
- h-index: 7
- Publications: 14
- Citations: 200
Selected Publications
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone (2025) DOI
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure (2025) DOI
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN (2024) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics